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Abstract
Pollen allergy is characterized by a TH2-biased immune response to pollen-derived allergens.
However, pollen-exposed epithelia do not encounter pure allergen but rather a plethora of protein
and non-protein substances. We demonstrated that pollen liberate lipids with chemical and
functional similarities to leukotriens and prostaglandins - the pollen associated lipid mediators
(PALMs). To date, two main groups of PALMs have been characterized: The immunostimulatory
PALMs activating innate immune cells such as neutrophils and eosinophils, and the
immunomodulatory E1-phytoprostanes blocking IL-12 production of dendritic cells, resulting in the
preferential induction of TH2 responses. This article reviews our work in the field of PALMs and
their effects on cells of the innate and adoptive immune system. From recent results a general
picture starts to emerge in which PALMs (and possibly other pollen-associated substances) may -
independently from protein allergens - propagate an overall TH2 favoring micromilieu in pollen
exposed tissue of predisposed individuals.
Background
Atopic diseases are characterized by a predominance of T
helper cell type 2 (TH2) biased immune responses to envi-
ronmental allergens. It is well established that allergen
specific TH2 cells are the key orchestrators of allergic reac-
tions, initiating and propagating inflammation through
the release of a number of TH2 cytokines. While the
importance of TH2 cells in allergy is well accepted, little is
known about the mechanisms that control the initial TH2
polarization in response to exogenous allergens. While for
some aeroallergens, foremost house dust mite Der p 1,
several intrinsic TH2 adjuvant effects have been reported
[1-3], most major pollen allergens seem to lack such char-
acteristics.
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A hallmark in the elucidation of adjuvant factors from
pollen was the discovery that pollen release NADPH oxi-
dases which increase reactive oxygen species in lung epi-
thelium thereby promoting neutrophil recruitment and
boosting allergic airway inflammation. In contrast, chal-
lenge with Amb a 1, the major ragweed allergen alone, did
not result in robust airway inflammation [4].
As link between innate and adaptive immune system,
dendritic cells (DCs) play a pivotal role in sensing envi-
ronmental danger signals such as bacterial or viral prod-
ucts, and in mounting a T cell-mediated immune response
against those potentially harmful invaders [5]. As profes-
sional antigen-presenting cells DCs reside in the periphery
in an immature state, where they take up pathogens or
allergens. Upon maturation, the cells undergo a series of
phenotypic changes: while their capability to phagocytose
antigen decreases, intracellular protein processing and
presentation, as well as the expression of co-stimulatory
markers are enhanced. The DCs acquire a migratory phe-
notype, serving their mission to transport the sampled
antigen to the secondary lymphoid tissues. The trafficking
of immature DCs to sites of inflammation and of mature
DCs to the T cell area of secondary lymphoid organs is reg-
ulated by the expression of different chemokines and
chemokine receptors [6].
In the defense against intracellular microbes or tumors,
the key cytokine secreted by DCs is IL-12 [7], which skews
T cell responses in the direction of TH1 [8]. IL-12 is
induced by pathogen associated molecular patterns such
as LPS or by T-cell derived signals such as IL-4 or CD40
ligation [9]. However, simultaneous presence of endog-
enous signals such as IL-10, TGF-, corticosteroids, vita-
min D3, or PGE2 can convert DC from TH1- to TH2-
skewing antigen presenting cells [10]. Recent studies dem-
onstrate that also exogenous factors such as lipids pro-
duced by parasites can modulate DC function for the
purposes of evading host immunity [11].
Besides their well established role in host defence, DCs are
also involved in hypersensitivity reactions against harm-
less environmental antigens, the allergens [12]. Indeed,
evidence emerges that DCs are not only key players in
allergic sensitization [13,14] but possibly even contribute
to maintaining and shaping the immune response to
allergens in already sensitized individuals [15,16]. Under-
standing the role of DCs in allergic sensitization has been
hampered, however, by the fact that to date only very few
signals have been identified that actively lead to a TH2
promoting DC phenotype [17,18].
We recently demonstrated that pollen, under physiologial
exposure conditions, release not only allergens but also
bioactive lipids. Among these are monohydroxylated
derivatives of linoleic and linolenic acid [19] that resem-
ble human Leucotriens and activate human neutrophils
and eosinophils in vitro. We then extended these data on
the impact of pollen associated lipid mediators on den-
dritic cell function. In brief, dinor isoprostanes (phyto-
prostanes) released from pollen grains under
physiological conditions are able to inhibit the DC's pro-
duction of IL-12 p70, and DC stimulated with aqueous
pollen extracts or E1-phytoprostanes become TH2 skewing
in mixed lymphocyte reaction. Additionally, DCs
matured in the presence of aqueous pollen extracts
respond by releasing TH2 attracting chemokines and
aquire a distinct migratory phenotype. Finally, we could
show that in a murine sensitization model, nasal instilla-
tion of OVA together with aqueous pollen extracts lead to
a TH2 shift in draining lymph node T cells. Taken together,
multiple lines of evidence imply that by modulating func-
tions of the innate and adaptive immune system, PALMs
add to creating a TH2 favoring, pro-allergic micromilieu.
Pollen release lipid mediators - the PALMs
It is commonly accepted that in susceptible individuals,
allergic sensitization results after allergens have been
taken up by antigen-presenting cells residing in the bar-
rier-forming epithelia like skin or airway mucosa. When
investigating this allergic sensitization phase, most studies
use purified allergen or allergen-extracts. Under physio-
logical exposure conditions, however, pollen-derived
allergens are not released alone, but rather in conjunction
with pollen granules, starch grains and other, non-protein
substances. One major constituent of pollen excine and
exsudate are lipids which are essential in the plant fertili-
zation process as they help the pollen tube to penetrate
the stigma [20]. This prompted us to investigate the
impact of the whole pollen grain on the human immune
system. We recently demonstrated that upon hydration,
pollen grains very rapidly release significant amounts of
lipids- the so-called pollen-associated lipid mediators
(PALMs) - that show structural and functional homology
to eicosanoids [21]. Since arachidonic acid metabolites
are well known to affect human innate and adaptive
immune responses we were prompted to further investi-
gate the effects of aqueous pollen extracts and their con-
stituents.
PALMs potently attract and activate PMN and 
eosinophils
The finding that pollen grains interact with cells of the
human immune system was made by Siegel and Sherman
as early as the seventies [22]. We were able to extend these
observations by investigating the outcome of granulocyte
- pollen interactions. Our data show that pollen grains
(birch and grass) attract and activate neutrophils [23] and
eosinophils [24] leading to the release of myeloperoxi-
dase and eosinophilic cationic protein, respectively.Allergy, Asthma & Clinical Immunology 2009, 5:3 http://www.aacijournal.com/content/5/1/3
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Chemotactic activity seemed to be independent of protein
allergen and could be demonstrated in aqueous pollen
extracts (APE) as well as in total lipid extracts (Hexane-iso-
propanol extracts, HIP) and reverse phase extracts of HIP,
enriched for mono-hydroxylated products of linoleic acid.
Chemotaxis of Eosinophils was blocked by the LTB4
receptor antagonist LY293111, whilst APE-induced cal-
cium influx in PMN was inhibited by pre-treatment with
LTB4 and vice versa in cross-sensitization experiments.
Interestingly, these effects seemed to be independent of
the sensitization status of the donor and thus might occur
in allergic and non-allergic individuals, further arguing for
allergen-independent effects. Taken together, these find-
ings indicate that, alongsinde the adaptive immune sys-
tem, innate mechanisms may also contribute to the
recognition of allergens within the respiratory tract.
PALMs confer a TH2 promoting phenotype on 
DCs
Apart from their effects on neutrophils and eosinophils
we investigated the impact of PALMs on human dendritic
cells - the initiators of T cell responses. As model, we
focused on human monocyte-derived dendritic cells
(moDCs). Interestingly, exposure of moDCs with LPS-
depleted aqueous birch pollen extracts (Bet.-APE) resulted
in a selective upregulation of HLA-DR surface expression,
while other maturation markers such as CD80, CD86,
CD40 and CD83 were not modulated. On LPS-matured
moDCs, Bet.-APE synergized with LPS in the up-regula-
tion of all maturation markers tested. At a functional level,
Bet.-APE stimulation of moDC resulted in an enhanced
allostimmulatory activity as demonstrated by enhanced
proliferative responses of naive allogeneic CD4+ T cells.
Importantly,  Bet.-APE treatment of moDCs induced a
dose dependent inhibition of the LPS or CD40L induced
IL-12 p70 production, while IL-6, IL-10 and TNF- pro-
duction were not impaired. Thus, water soluble factors
released from pollen grains are capable to selectively
modulate various DC functions, including the inhibition
of the key TH1 cytokine IL-12 p70 [25].
By means of gas chromatography-mass spectometry anal-
ysis of Bet.-APE, we demonstrate the presence of E1-, F1-,
A1/B1-phytoprostanes in aqueous pollen extracts (see
table 1) and show that E1-phytoprostanes - similar to Bet.-
APE - dose-dependently inhibit the IL-12 p70 production
while not affecting IL-6 production. Like in the case of
Bet.-APE, pre-treatment of moDC with E1-phytoprostanes
results in an increased IL-4/IFN- ratio in CD4+ T cells after
allogenic mixed lymphocyte reaction. Thus, PPE1 could be
identified as one of the substances contained in Bet.-APE
which mediate the TH2 polarizing capacity of moDCs
[25].
Aqueous pollen extracts modulate chemokine/
chemokine receptor expression and migratory 
capacity of DCs
Maturation of DCs results in substantial changes in the
surface expression of T cell costimulatory molecules like
HLA-DR, CD40, CD86 and CD80. Concomitantly, matur-
ing DCs undergo distinct changes in the expression of
chemokine receptors, licensing them to migrate towards
chemokine gradients [26]. In a more recent study we
therefore examined the effects of aqueous birch pollen
extracts (Bet.-APE) on chemokine production, chemokine
receptor expression and migratory capacity of moDCs
[27]. Here we found that on immature DCs, Bet.-APE
induced expression and function of CXCR4, which might
be critical for directing DCs to lymphoid organs during
allergic inflammation. Concomitantly, Bet.-APE reduced
surface expression of CCR1 and CCR5, reflecting DC mat-
uration and acquisition of a "pro-inflammatory" pheno-
type [26]. In addition, maturation of DCs with LPS in the
presence of Bet.-APE impaired the LPS-induced produc-
tion of the TH1 attracting chemokines CXCL10 and CCL5.
Instead, the cells show an enhanced release of the "TH2"
chemokine CCL22. The release of CCL17, a chemokine
enhanced in atopic ekzema, was not significantly changed
as compared to LPS treatment alone. At a functional level,
Bet.-APE increased the capacity of LPS-matured DCs to
migrate towards CXCL12 - as reflected by the enhanced
expression of CXCR4 - and towards the lymph node hom-
ing chemokines CCL19 and CCL21. These effects of Bet.-
APE depended on adenylyl cyclase and cAMP induction
and strongly mimicked some key characteristics of PGE2
[28,29]. Finally, culture supernatants of DCs matured in
the presence of LPS and Bet.-APE attracted TH2 cells in
transwell chamber migration assays, while the capacity to
recruit TH1 cells was reduced. This might imply that pol-
len-exposed DCs favor the maintainance of already estab-
lished TH2 immune responses. Importantly, all effects
summarized above were observed in DCs derived from
monocytes of non-atopic donors. In our view this sup-
ports the concept of allergen-independent adjuvant effects
Table 1: Concentrations of phytoprostanes in aqueous birch pollen extracts (modified from [25]).
Concentration in Bet.-APE (10 mg/mL) (nM) Concentration (g/g pollen)
PPE1 543.6 +/- 41.1 17.72 +/- 1.34
PPF1 68.6 +/- 1.5 2.25 +/- 0.05
PPA1/B1 23.8.6 +/- 3.5 0.74 +/- 0.11Allergy, Asthma & Clinical Immunology 2009, 5:3 http://www.aacijournal.com/content/5/1/3
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of pollen shifting the primary immune response towards
TH2 in susceptible individuals (see table 2).
Factors from pollen lead to a preferential 
induction of TH2 responses in vivo
Only recently we were able to undermine our in vitro data
by studies in a murine sensitization model [30]. OVA-spe-
cific CD4+ T cells were adoptively transferred into BALB/c
mice. Twenty-four hours later, mice were challenged by
means of intranasal application of OVA in the absence or
presence of Bet.-APE or phytoprostanes -E1 or -F1. Polari-
zation of T-cell responses in vivo was analyzed in draining
lymph node T cells. While intranasal instillation of phyto-
prostanes down-regulated both TH1 and TH2 cytokines,
inhalation of Bet.-APE lead to a selective down-regulation
of IFN- and an up-regulation of the TH2 cytokines IL-4,
IL-5 and IL-13. This implies that water-soluble factors
Table 2: Summary of effects of PALMs on cells of the innate and 
adoptive immune system
PMN Eosinophils Dendritic cells
Chemotaxis* Chemotaxis# IL-12¶
Calcium influx* TH2 bias in MLR¶
CD11b* CD11b# cAMPi§
Release of MPO* Release of ECP# CXCR4§
CCR5, CCR1§
CCL22§
CXCL10, CCL5§
Arrows indicate an increase () or decrease ().
References: *: Traidl-Hoffmann C et al., J Allergy Clin Immunol 
(2002); #: Plötz SG et al., J Allergy Clin Immunol (2004); ¶: Traidl-
Hoffmann C et al., J Exp Med (2005); §: Mariani V et al., J Immunol 
(2007)
cAMPi = intracellular cyclic 5'-adenosine monophosphate; ECP = 
eosinophil cationic protein; MLR = mixed lymphocyte reaction.
Hypothetical model of a TH2 dominated adoptive immune response and local TH2 promoting micromilieu induced by pollen- associated lipid mediators Figure 1
Hypothetical model of a TH2 dominated adoptive immune response and local TH2 promoting micromilieu 
induced by pollen-associated lipid mediators. When pollen grains are hydrated on the respiratory epithelia, they release 
allergens and eicosanoid lipids, the so-called pollen-associated lipid mediators (PALMs). Leucotrien-like PALMs have the poten-
tial to attract and activate innate cells like neutrophils and eosinophils, while prostaglandin-like PALMs, the phytoprostanes, and 
possibly other pollen-derived factors, can modulate the migratory and T helper cell polarizing capacities of resident dendritic 
cells. In addition, DCs exposed to PALMs might be induced to secrete chemokines which preferentially recruit further TH2 
cells to the site of pollen exposure. Taken together, the possible effects of PALMs on both cells of the innate and the adoptive 
immune system might lead to a local microenvironment favoring TH2 responses. I FN- = interferon-; IL = interleukin; PC = 
plasma cellAllergy, Asthma & Clinical Immunology 2009, 5:3 http://www.aacijournal.com/content/5/1/3
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released from pollen might confer a TH2 polarizing capac-
ity independently from phytoprostanes. The identifica-
tion of those water-soluble substance(s) and dissecting
their respective contributions to allergic sensitization or
exacerbation should add to our general understanding of
the mechanisms of pollen-induced allergy and might ulti-
mately lead to the development of new therapeutic strate-
gies.
In summary, pollen release regulatory mediators which
might add to the generation of an overall TH2 promoting
micro milieu. First, pollen provide signals for DCs to
mature and acquire a migratory phenotype, preferentially
priming type 2 T helper cell responses. The latter effect is
partly mediated by E1-phytoprostanes, but other sub-
stances are likely to play a role. Secondly, PALMs might
help to maintain an established TH2 response by preferen-
tial recruitment of TH2 cells and other inflammatory cells
(neutrophils, eosinophils) to the site of pollen exposure
(Figure 1) (see also table 2).
Abbreviations
APE: aqueous pollen extract(s); Bet.-APE: aqueous birch
pollen extracts; DC: dendritic cell; MoDC: monocyte-
derived dendritic cell; OVA: ovalbumin; PALM: pollen-
associated lipid mediator
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors contributed equally to the manuscript. All
authors have read and approved the final manuscript.
Acknowledgements
The study was supported by a Bundesministerium für Bildung und Forschung 
(BMBF) grant to T.J. and C.T.-H, V.M. was supported by a research fellow-
ship from the Bayerische Forschungsstiftung, C.T.-H. was a recipient of the 
Bayerische Habilitationsförderpreis.
References
1. Chapman MD, Wunschmann S, Pomes A: Proteases as Th2 adju-
vants.  Curr Allergy Asthma Rep 2007, 7:363-367.
2. Comoy EE, Pestel J, Duez C, Stewart GA, Vendeville C, Fournier C,
Finkelman F, Capron A, Thyphronitis G: The house dust mite
allergen, Dermatophagoides pteronyssinus, promotes type 2
responses by modulating the balance between IL-4 and IFN-
gamma.  J Immunol 1998, 160:2456-2462.
3. Traidl-Hoffmann C, Jakob T, Behrendt H: Determinants of aller-
genicity.  J Allergy Clin Immunol 2008, 123:558-566.
4. Boldogh I, Bacsi A, Choudhury BK, Dharajiya N, Alam R, Hazra TK,
Mitra S, Goldblum RM, Sur S: ROS generated by pollen NADPH
oxidase provide a signal that augments antigen-induced
allergic airway inflammation.  J Clin Invest 2005, 115:2169-2179.
5. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulen-
dran B, Palucka K: Immunobiology of dendritic cells.  Annu Rev
Immunol 2000, 18:767-811.
6. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S,
Briere F, Zlotnik A, Lebecque S, Caux C: Selective recruitment of
immature and mature dendritic cells by distinct chemokines
expressed in different anatomic sites.  J Exp Med 1998,
188:373-386.
7. Trinchieri G, Scott P: Interleukin-12: a proinflammatory
cytokine with immunoregulatory functions.  Res Immunol 1995,
146:423-431.
8. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper
JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A: Dendritic
cells produce IL-12 and direct the development of Th1 cells
from naive CD4+ T cells.  J Immunol 1995, 154:5071-5079.
9. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A,
Alber G: Ligation of CD40 on dendritic cells triggers produc-
tion of high levels of interleukin-12 and enhances T cell stim-
ulatory capacity: T-T help via APC activation.  J Exp Med 1996,
184:747-752.
10. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML: T-cell prim-
ing by type-1 and type-2 polarized dendritic cells: the con-
cept of a third signal.  Immunol Today 1999, 20:561-567.
11. Angeli V, Faveeuw C, Roye O, Fontaine J, Teissier E, Capron A,
Wolowczuk I, Capron M, Trottein F: Role of the parasite-derived
prostaglandin D2 in the inhibition of epidermal Langerhans
cell migration during schistosomiasis infection.  J Exp Med
2001, 193:1135-1147.
12. Jakob T, Traidl-Hoffmann C, Behrendt H: Dendritic cells--the link
between innate and adaptive immunity in allergy.  Curr Allergy
Asthma Rep 2002, 2:93-95.
13. Eisenbarth SC, Piggott DA, Bottomly K: The master regulators of
allergic inflammation: dendritic cells in Th2 sensitization.
Curr Opin Immunol 2003, 15:620-626.
14. Lambrecht BN: Dendritic cells and the regulation of the aller-
gic immune response.  Allergy 2005, 60:271-282.
15. Novak N, Bieber T: The role of dendritic cell subtypes in the
pathophysiology of atopic dermatitis.  J Am Acad Dermatol 2005,
53(2 Suppl 2):S171-176.
16. Novak N, Valenta R, Bohle B, Laffer S, Haberstok J, Kraft S, Bieber T:
FcepsilonRI engagement of Langerhans cell-like dendritic
cells and inflammatory dendritic epidermal cell-like den-
dritic cells induces chemotactic signals and different T-cell
phenotypes in vitro.  J Allergy Clin Immunol 2004, 113:949-957.
17. Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P: The para-
digm of type 1 and type 2 antigen-presenting cells. Implica-
tions for atopic allergy.  Clin Exp Allergy 1999, 2:33-36.
18. Moore ML, Peebles RS Jr: Update on the role of prostaglandins
in allergic lung inflammation: separating friends from foes,
harder than you might think.  J Allergy Clin Immunol 2006,
117:1036-1039.
19. Thoma I, Krischke M, Loeffler C, Mueller MJ: The isoprostanoid
pathway in plants.  Chem Phys Lipids 2004, 128:135-148.
20. Wolters-Arts M, Lush WM, Mariani C: Lipids are required for
directional pollen-tube growth.  Nature 1998, 392:818-821.
21. Behrendt H, Kasche A, Ebner von Eschenbach C, Risse U, Huss-Marp
J, Ring J: Secretion of proinflammatory eicosanoid-like sub-
stances precedes allergen release from pollen grains in the
initiation of allergic sensitization.  Int Arch Allergy Immunol 2001,
124:121-125.
22. Siegel I, Sherman WB: Pollen-white cell interactions.  J Allergy
1970, 45:133-145.
23. Traidl-Hoffmann C, Kasche A, Jakob T, Huger M, Plotz S, Feussner I,
Ring J, Behrendt H: Lipid mediators from pollen act as chem-
oattractants and activators of polymorphonuclear granulo-
cytes.  J Allergy Clin Immunol 2002, 109:831-838.
24. Plotz SG, Traidl-Hoffmann C, Feussner I, Kasche A, Feser A, Ring J,
Jakob T, Behrendt H: Chemotaxis and activation of human
peripheral blood eosinophils induced by pollen-associated
lipid mediators.  J Allergy Clin Immunol 2004, 113:1152-1160.
25. Traidl-Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring
J, Mueller MJ, Jakob T, Behrendt H: Pollen-associated phytopros-
tanes inhibit dendritic cell interleukin-12 production and
augment T helper type 2 cell polarization.  J Exp Med 2005,
201:627-636.
26. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR,
Qin S, Lanzavecchia A: Rapid and coordinated switch in chem-
okine receptor expression during dendritic cell maturation.
Eur J Immunol 1998, 28:2760-2769.
27. Mariani V, Gilles S, Jakob T, Thiel M, Mueller MJ, Ring J, Behrendt H,
Traidl-Hoffmann C: Immunomodulatory mediators from pol-
len enhance the migratory capacity of dendritic cells and
license them for Th2 attraction.  J Immunol 2007,
178:7623-7631.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Allergy, Asthma & Clinical Immunology 2009, 5:3 http://www.aacijournal.com/content/5/1/3
Page 6 of 6
(page number not for citation purposes)
28. Legler DF, Krause P, Scandella E, Singer E, Groettrup M: Prostaglan-
din E2 is generally required for human dendritic cell migra-
tion and exerts its effect via EP2 and EP4 receptors.  J Immunol
2006, 176:966-973.
29. Scandella E, Men Y, Legler DF, Gillessen S, Prikler L, Ludewig B,
Groettrup M: CCL19/CCL21-triggered  signal transduction
and migration of dendritic cells requires prostaglandin E2.
Blood 2004, 103:1595-1601.
30. Gutermuth J, Bewersdorff M, Traidl-Hoffmann C, Ring J, Mueller MJ,
Behrendt H, Jakob T: Immunomodulatory effects of aqueous
birch pollen extracts and phytoprostanes on primary
immune responses in vivo.  J Allergy Clin Immunol 2007,
120:293-299.